Pharmafile Logo
Pharmafocus logo
Advanced Search
Lilly image

Lilly plans trio of launches

October 4, 2013
Research and Development, Sales and Marketing lilly, pipeline

Lilly plans to launch at least three new medicines next year, senior managers announced during a meeting with analysts and …

News
fenella_grey_high_res

Porter Novelli hires deputy managing director

October 4, 2013
Medical Communications, Sales and Marketing Porter Novelli

PR firm Porter Novelli has announced that Fenella Grey has been named as its deputy managing director. Grey joined the …

Appointment

Global cancer crisis flagged in report

October 3, 2013
Medical Communications, Research and Development, Sales and Marketing IPRI, Roche, wprld prevention alliance

A new report advocates the formation of a major industry-backed initiative to tackle the world’s growing cancer burden.  Sponsored by …

News
alderley image

More companies join AZ’s BioHub

October 3, 2013
Research and Development, Sales and Marketing AstraZeneca, Cambridge, alderley

Half a dozen more bioscience companies are to become tenants at the Alderley Park BioHub in Cheshire, filling some of …

News
deesha_4c

4C Consultants International announces two hires

October 3, 2013
Medical Communications, Sales and Marketing

Deesha Majithia and Helen Jones have joined comms agency 4C Consultants International. Majithia joins the firm as a project manager …

Appointment
mabthera image

NICE U-turn on MabThera

October 3, 2013
Sales and Marketing MabThera, NHS, NICE, Roche

NICE is thinking about recommending Roche’s MabThera for a rare autoimmune condition – a move which represents a partial victory …

News
Merck sign

Merck axes 8,500 more jobs

October 2, 2013
Medical Communications, Research and Development, Sales and Marketing Jobs, Merck, R&D, cuts

News
FDA image

US shutdown starts to bite – UPDATED

October 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare

Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …

News
Vaccine image

Calls to end UK anti-vaccine magazine

October 2, 2013
Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science

British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …

News

Hunt: ‘We will never cover up’

October 2, 2013
Sales and Marketing CQC, Cameron, Hunt, NHS

In a speech which mixed the personal and the political at the Conservative Party conference in Manchester yesterday, health secretary …

News
roxanne_tavakkol

TKL Research hires VP of regulatory affairs

October 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roxanne Tavakkol, TKL research

Clinical research organisation TKL Research has appointed Roxanne Tavakkol to the position of vice president, regulatory and scientific services. Tavakkol …

Appointment

SHL GM Frank Isaksson signs second LOI to further increase investments in Taiwan

October 2, 2013
Manufacturing and Production auto injector, frank isaksson, pen injector, shl capacity, shl expansion

SHL Group, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, signed a second Letter of …

News
Press release

SHL Group invests in new KraussMaffei molding machines for medical device production

October 2, 2013
Manufacturing and Production auto injectors, autoinjector, pen injector, shl kraussmaffei

As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in …

News
Press release
Perjeta image

Perjeta becomes first approved drug for early breast cancer

October 1, 2013
Sales and Marketing FDA, Herceptin, Perjeta, Roche

Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …

News
ceravix image

MHRA: Cervarix ‘in clear’

October 1, 2013
Sales and Marketing GSK, Gardasil, MHRA, ceravix

Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …

News
Belén Garijo image

Merck makes big changes at the top

October 1, 2013
Medical Communications, Sales and Marketing Merck, Merck Serono

Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …

News
gsk image

Aspen buys GSK plant and thrombosis drugs for $1.1 billion

October 1, 2013
Manufacturing and Production, Sales and Marketing GSK, aspen

South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …

News

Cancer survival rates linked to government spending in EU

October 1, 2013
Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

News
boehringer image

Boehringer cancer drug impresses

October 1, 2013
Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …

News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013
Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026